✨ New Arrivals Just Dropped!Explore
RETADESARTZ Candesartan Cilexetil Angiotensin II Antagonist 8mg Tablet 30's
HomeStore

RETADESARTZ Candesartan Cilexetil Angiotensin II Antagonist 8mg Tablet 30's

RETADESARTZ Candesartan Cilexetil Angiotensin II Antagonist 8mg Tablet 30's

Generic Name: Candesartan Cilexetil
Brand Name: RETADESARTZ
Strength: 8MG
Quantity: 30S
Type: Tablet

Philippines FDA Registration Number: To be updated.

Product Description:
RETADESARTZ contains Candesartan Cilexetil, an angiotensin II receptor blocker (ARB) used to lower high blood pressure and manage heart failure. It works by blocking the action of angiotensin II, relaxing blood vessels, and improving blood flow, thereby reducing cardiovascular risks.

$6.37
RETADESARTZ Candesartan Cilexetil Angiotensin II Antagonist 8mg Tablet 30's—
$6.37

More Images

RETADESARTZ Candesartan Cilexetil Angiotensin II Antagonist 8mg Tablet 30's - Image 2
RETADESARTZ Candesartan Cilexetil Angiotensin II Antagonist 8mg Tablet 30's - Image 3

RETADESARTZ Candesartan Cilexetil Angiotensin II Antagonist 8mg Tablet 30's

Generic Name: Candesartan Cilexetil
Brand Name: RETADESARTZ
Strength: 8MG
Quantity: 30S
Type: Tablet

Philippines FDA Registration Number: To be updated.

Product Description:
RETADESARTZ contains Candesartan Cilexetil, an angiotensin II receptor blocker (ARB) used to lower high blood pressure and manage heart failure. It works by blocking the action of angiotensin II, relaxing blood vessels, and improving blood flow, thereby reducing cardiovascular risks.

Product Information

Shipping & Returns

Description

Generic Name: Candesartan Cilexetil
Brand Name: RETADESARTZ
Strength: 8MG
Quantity: 30S
Type: Tablet

Philippines FDA Registration Number: To be updated.

Product Description:
RETADESARTZ contains Candesartan Cilexetil, an angiotensin II receptor blocker (ARB) used to lower high blood pressure and manage heart failure. It works by blocking the action of angiotensin II, relaxing blood vessels, and improving blood flow, thereby reducing cardiovascular risks.